$200 for 30 Tablets of Gefitinib EGFR Inhibitor for NSCLC

This medicine, gefitinib, is specially used for a type of lung cancer known as NSCLC. It targets those with specific changes in a part of the gene called EGFR. Specifically, it helps people who have a deleted part of EGFR (exon 19) or certain mutations (like L858R) in a different part of the gene (exon 21).

The medicine’s job is to block a signal from a protein called EGFR, which controls cell growth. The drug is available as 250 mg tablets. The usual dose is a 250 mg pill taken every day—whether you eat first or not is up to you.

One bottle holds 30 pills, which is about a 10-day supply for your treatment.